ImmunityBio, Inc. IBRX

Science aside let’s consider PSS. The toughest nut to crack is charting your way the the approval process unquestionably. He is a seasoned veteran with the FDA and knows step by step how to move. The legal bullshit is o nonevent. It’s about data, data and data. The drug sells itself

Not approving a drug this effective would be a crime against humanity. It WILL be approved period….

I mean cmon badgers does it get more convincing than this? It’s a wrap I’ve seen 15% efficacy garbage get approved and this with these numbers?

The homework is done. It’s enroute

I’m sure it’s over. They will announce discontinued trials and lock the doors

Question here is PSS selling or buying shares?

Ask Geert from CVM how impossible the FDA is currently. Trump gutted them and Covid put them years behind. It’s monumental to clear hurdles quickly

It could be Mercks ticket to extended patent safety and higher efficacy. What’s that worth to Merck alone not even considering others.

Please! It’s revolutionary

Your like a guy that can’t stop jerking off!